Makers Laboratories has received approval from board of directors for acquiring/ purchasing/ investing in the Equity Shares of Resonance Specialties through negotiated deal either by way of open market purchase or through a share purchase agreement or both with willing sellers and also acquire controlling interest in Resonance Specialties along with Kaygee Investments, a person acting in concert. As per the Share Purchase Agreement, the company will acquire 45.48% voting rights in the Resonance Specialties and Kaygee Investments, a person acting in concert will acquire 8.76% voting rights. This acquisition is subject to all the requisite regulatory approvals.
The Board of Directors of the Company have also approved making of an Open Offer, along with Kaygee Investments being a person acting in concert, to the public shareholders of the Resonance Specialties pursuant to the applicable provisions of the Securities and Exchange Board of India (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Makers Laboratories is engaged in manufacturing pharmaceutical formulations and drug intermediaries. The product portfolio of the company includes Tablets & Capsules,Liquids (Oral),Injectables,Drugs (Intermediates)and Creams & Ointments.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.85 |
Dr. Reddys Lab | 5812.50 |
Cipla | 1403.90 |
Zydus Lifesciences | 1104.45 |
Lupin | 1661.90 |
View more.. |